970
Views
0
CrossRef citations to date
0
Altmetric
Influenza – Brief Report

Hospitalization and risk of death due to influenza among vaccinated and unvaccinated patients. A 5-year study in the northeastern Mexican population

, , , &
Article: 2150474 | Received 04 Jul 2022, Accepted 18 Nov 2022, Published online: 01 Dec 2022

References

  • Cope RC, Ross JV, Chilver M, Stocks NP, Mitchell L. Characterising seasonal influenza epidemiology using primary care surveillance data. PLoS Comput Biol. [Internet]. 2018 [cited 2022 Jul 2];14(8):e1006377. doi:10.1371/journal.pcbi.1006377.
  • Epperson S, Davis CT, Brammer L, Elal1 AIA, Ajayi N, Barnes J, Budd AP, Burns E, Daly P, Dugan VG, et al. Update: influenza activity — United States and worldwide, May 19–September 28, 2019, and composition of the 2020 southern hemisphere influenza vaccine. Morb Mort Wkly Rep. [Internet]. 2019 [cited 2022 Jul 2];68(40):880. doi:10.15585/mmwr.mm6840a3.
  • Hendriks J, Hutubessy RCW, Grohmann G, Torelli G, Friede M, Kieny MP. Quadrivalent influenza vaccines in low and middle income countries: cost-effectiveness, affordability and availability. Vaccine. [Internet]. 2018 [cited 2022 Jul 2];36(28):3993–5. doi:10.1016/j.vaccine.2018.05.099.
  • Castillejos M, Cabello-Gutiérrez C, Alberto Choreño-Parra J, Hernández V, Romo J, Hernández-Sánchez F, Martínez D, Hernández A, Jiménez-Álvarez L, Hernández-Cardenas CM, et al. High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico. Int J Infect Dis. [Internet]. 2019 [cited 2022 Jul 2];89:87–95. doi:10.1016/j.ijid.2019.08.029.
  • Falcón-Lezama JA, Saucedo-Martínez R, Betancourt-Cravioto M, Alfaro-Cortes MM, Bahena-González RI, Tapia-Conyer R. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children. BMC Infect Dis. 2020;20(1):20. doi:10.1186/s12879-020-4948-5.
  • Salto-Quintana JN, Rivera-Alfaro G, Sánchez-Ramos EL, Gómez-Gómez A, Noyola DE. Post-pandemic influenza-associated mortality in Mexico. Pathog Glob Health. [Internet]. 2019 [cited 2022 Jul 2];113(2):67–74. doi:10.1080/2047772420191589211.
  • Savy V, Ciapponi A, Bardach A, Glujovsky D, Aruj P, Mazzoni A, Gibbons L, Ortega-Barría E, Colindres RE. Burden of influenza in Latin America and the Caribbean: a systematic review and meta‐analysis. Influenza Other Respir Viruses. [Internet]. 2013 [cited 2022 Jul 2];7(6):1017. doi:10.1111/irv.12036.
  • Esquema de Vacunación | Secretaría de Salud | Gobierno | gob.mx [Internet]. [cited 2022 Jul 2]. https://www.gob.mx/salud/articulos/esquema-de-vacunacion.
  • Romero-Martínez M, Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Mojica-Cuevas J, Cuevas-Nasu L, Rivera-Dommarco J, Gómez-Humarán M, Gaona-Pineda EB, Gómez-Acosta LM, et al. Encuesta Nacional de Salud y Nutrición 2018–19: metodología y perspectivas. Salud Pública de México. 2019 [cited 2022 Jul 2];61(6, nov–dic):917–23. doi:10.21149/11095.
  • Perfil clínico-epidemiológico de las defunciones por influenza con antecedente de vacunación oportuna, México 2010–2018. [Internet]. [cited 2022 Jul 2]. https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=90067.
  • Santos GM R-P, Betancourt-Cravioto M, Espinosa-Rosales FJ, Rivas-Ruiz R, Guerrero-Almeida MC, de Lourdes Guerrero-Almeida M, Hernández-Porras M, Macías-Hernández AE, Macías-Parra M, Moreno-Espinosa S, et al. Vacunación universal contra el virus de la influenza: consenso de expertos en México Universal influenza vaccination: a Mexican Expert Position Paper Correspondencia: GACETA MÉDICA DE MÉXICO. 2021 [cited 2022 Jul 2]. www.gacetamedicademexico.com .
  • Tapia‐Conyer R, Betancourt‐Cravioto M, Montoya A, Falcón‐Lezama JA, Alfaro‐Cortes MM, Saucedo‐Martínez R. A call for a reform of the influenza immunization program in Mexico: epidemiologic and economic evidence for decision making. Vaccines. [Internet]. 2021 [cited 2022 Jul 2];9(3):286. doi:10.3390/vaccines9030286.
  • WHO information for the molecular detection of influenza viruses It is strongly recommended that all un-subtypeable influenza a specimens of human origin, that may represent either seasonal viruses displaying significant genetic/antigenic drift or zoonotic viruses/events with pandemic potential, should be immediately sent for detailed characterization to one of the six WHO Collaborating Centres (WHO CC) 1 for Reference & Research on Influenza. 2021 [cited 2022 Oct 1]. http://www.who.int/influenza/gisrs_laboratory/collaborating_centres/list/en/index.html.
  • CDC protocol of realtime RTPCR for swine influenza A(H1N1). 2009 [accessed 2022 October 28]. http://cidbimena.desastres.hn/docum/AH1N1/CDCrealtimeRTPCRprotocol_20090428.pdf.
  • Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, Orton E, Béchard-Evans L, Morgan G, Stevenson C, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One. 2011;6(12):6. doi:10.1371/journal.pone.0029249.
  • Martínez-Baz I, Navascués A, Pozo F, Chamorro J, Albeniz E, Casado I, Reina G, Cenoz MG, Ezpeleta C, Castilla J, et al. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccin Immunother. [Internet]. 2015 [cited 2022 Jul 2];11(7):1626–33. doi:10.1080/21645515.2015.1038002.
  • Ridenhour BJ, Campitelli MA, Kwong JC, Rosella LC, Armstrong BG, Mangtani P, Calzavara AJ, Shay DK, Sambhara S. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS One. [Internet]. 2013 [cited 2022 Jul 2];8(10):e76318. doi:10.1371/journal.pone.0076318.
  • Cheng AC, Kotsimbos T, Kelly PM, Wark P, Hunter C, Hewagama S, Friedman ND, Korman TM, Simpson G, Upham JW, et al. Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014. Vaccine. 2015;33(51):7352–56. doi:10.1016/j.vaccine.2015.10.016.
  • Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009–10. BMJ. [Internet]. 2012 [cited 2022 Jul 2];344. https://www.bmj.com/content/344/bmj.d7901.
  • Restivo V, Costantino C, Bono S, Maniglia M, Marchese V, Ventura G, Casuccio A, Tramuto F, Vitale F. Influenza vaccine effectiveness among high-risk groups: a systematic literature review and meta-analysis of case-control and cohort studies. Hum Vaccin Immunother. [Internet]. 2018 [cited 2022 Jul 2];14(3):724. doi:10.1080/21645515.2017.1321722.
  • Taksler GB, Rothberg MB, Cutler DM. Association of influenza vaccination coverage in younger adults with influenza-related illness in the elderly. Clin Infect Dis. [Internet]. 2015 [cited 2022 Jul 2];61(10):1495. doi:10.1093/cid/civ630.